BTIG Starts T2 Biosystems, Inc (TTOO) at Buy
- S&P 500, Nasdaq hit record closing peaks on eve of Fed meeting
- Oil steadies after hitting 2-yr high as demand hopes face supply growth
- Bitcoin (BTC) Price Pops 10% as Tesla's Musk Signals Another U-Turn on Bitcoin Payments
- Lordstown Motors (RIDE): CEO and CFO Resign, Presents Results of Investigation Of Hindenburg Research Report
- Paul Tudor Jones is 'Probably' Buying Commodities, Crypto, Gold if Fed Continues to Ignore Inflation Concerns, Endorses Bitcoin (BTC) as a Portfolio Diversifier
BTIG initiates coverage on T2 Biosystems, Inc (NASDAQ: TTOO) with a Buy rating and a price target of $2.50.
Shares of T2 Biosystems, Inc closed at $1.29 yesterday.
You May Also Be Interested In
- UPDATE: Wolfe Research Starts Medical Properties Trust (MPW) at Peerperform
- Wolfe Research Starts Essex Property Trust (ESS) at Peerperform
- Street Largely Bullish on Squarespace (SQSP) on Attractive E-Commerce Services Opportunity and Strong Profitability Growth
Create E-mail Alert Related CategoriesNew Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!